
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 11
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT04354389 | DAS181 for STOP COVID-19 | ||
NCT00527865 | Single Dose Escalating Study of DAS181 in Adults | ||
NCT04298060 | DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19) | ||
NCT04324489 | DAS181 for Severe COVID-19: Compassionate Use | ||
NCT03808922 | Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study | ||
NCT01740063 | Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza | ||
NCT01113034 | A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis | ||
NCT01924793 | An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection | ||
NCT01037205 | Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed Influenza | ||
NCT00876161 | DAS181 Single Dose Escalation Study in Healthy Adults | ||
NCT01644877 | A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen |